Connect Biopharma Holdings Ltd
CNTB · XNASCIK 1835268fmd_0S685DWSKGKK566309GMTNFY78Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2019 to Jun 30, 2026, 18 periods
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total revenues | – | – | 0 | 26 | 0 |
| Research and development | 80 | 97 | 53 | 29 | 38 |
| Total operating expenses | – | – | 69 | 48 | 58 |
| Operating income | (98) | (119) | (69) | (22) | (58) |
| Interest expense | 0 | 0 | 0 | – | – |
| Other non-operating income (expense) | – | – | 7 | 7 | 3 |
| Income before taxes | (202) | (118) | (62) | (15) | (55) |
| Income tax expense | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (202) | (118) | (62) | (16) | (55) |
| Net income | (202) | (118) | (62) | (16) | (55) |